You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動丨甘李藥業(603087.SH)漲5.68% 賴脯胰島素注射液獲黎巴嫩註冊批件
格隆匯 08-25 13:45
格隆匯8月25日丨甘李藥業(603087.SH)漲5.68%,報83.4元,高見85.49元創逾一個月新高,總市值468億元。繼8月21日公吿公司甘精胰島素在巴拉圭商業化獲批後,昨晚,甘李藥業再次發佈公吿稱公司賴脯胰島素注射液在黎巴嫩獲得藥品註冊批件。據悉,本次是甘李藥業自主研發的賴脯胰島素首次海外獲批,具有重要的里程碑意義。同時也是繼其甘精胰島素注射液在黎巴嫩正式商業化後,產品再度在中東區域的深入商業拓展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account